Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Emergent BioSolutions (NYSE: EBS) will report fourth quarter and full year 2025 financial results and host a conference call on Thursday, February 26, 2026 at 5:00 PM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Emergent BioSolutions (NYSE: EBS) will report fourth quarter and full year 2025 financial results and host a conference call on Thursday, February 26, 2026 at 5:00 PM ET.
Investors can join via live webcast on the company’s Investors page or by telephone after registering in advance; a replay will be posted on the Investors page.
Details
News Market Reaction – EBS
On Feb 12, the day this news came out, EBS closed 1.63% below the previous close.
Data tracked by StockTitan Argus for the Feb 12 session.
Key Figures
- Earnings call date
- February 26, 2026
- Scheduled Q4 and full-year 2025 results discussion
- Earnings call time
- 5:00 pm ET
- Start time of Q4 and full-year 2025 conference call
- Announcement date
- February 12, 2026
- Date earnings-call press release was issued
Historical Context
-
FDA approved supplemental NDA for new NARCAN® Nasal Spray carrying case.
-
Voluntary prepayment of $100 million on term loan, reducing gross debt.
-
Delivery order up to $21.5 million for BioThrax® anthrax vaccine supply.
-
Additional backing for Africa CDC-led MOSA mpox study with no safety concerns.
-
Announcement of presentation at the 44th Annual J.P. Morgan Healthcare Conference.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
GAITHERSBURG, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, February 26, 2026, at 5:00 pm eastern time to discuss the financial results for the fourth quarter and full year of 2025.
Participants can access the conference call live via webcast and also by visiting the Investors page of Emergent’s website. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
At Emergent, our mission is to protect and save lives. For over 25 years, we’ve been at work preparing those entrusted with protecting public health. We deliver protective and life-saving solutions for health threats like smallpox, mpox, botulism, Ebola, anthrax and opioid overdose emergencies. To learn more about how we help prepare communities around the world for today’s health challenges and tomorrow’s threats, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.